Research Paper Volume 13, Issue 14 pp 18701—18717
Development and validation of a novel epigenetic-related prognostic signature and candidate drugs for patients with lung adenocarcinoma
Figure 4. Establishment of epigenetic-related prognostic signature. (A) Screening of optimal parameter (lambda) at which the vertical lines were drawn. (B) Lasso coefficient profiles of these ERGs with non-zero coefficients determined by the optimal lambda.